marginally non-significantp = 0.051
A marginally non-significant ( p = 0.051) association of CB leptin concentration and weight change was observed.
A marginally non-significant ( p = 0.051) association of CB leptin concentration and weight change was observed.
Whey protein supplementation resulted in a borderline significant ( p = 0.051) greater weight loss but also in a significantly greater absolute fat-free mass loss.
The difference-in-difference in high-quality diets between depressed and non-depressed Latinas and Latinas who met and did not meet physical activity guidelines was statistically significant for total fruit ( p < 0.01) and approaching significance for total HEI ( p = 0.051) and sea/plant protein ( p = 0.052).
In follow-up, there was a borderline significant result in cognitive SR skills when comparing low PEL intervention and control groups ( p = 0.051).
When the model was adjusted for age, gender, and BMI, the association of IPA levels remained borderline significant for lobular inflammation ( p = 0.051) and fibrosis ( p = 0.076). 3.2.
More than 80% of the children met their recommended daily protein intake, but the difference between the two regions tended toward significance in the 6–12-months-old group ( p = 0.051) but not the 12–36-months-old group ( p = 0.231) ( Table 4 ).
The main effect of Group was only marginally significant (F 1,111 = 3.88; p = 0.051; pƞ 2 = 0.03).
Body Composition After about eight months of nutritional counselling, the adolescent athletes increased their MAMC, while and showed a trend towards significance to increase their lean mass ( p = 0.051).
This effect remained significant for r = 0.9 (SMD = 0.52, p = 0.032) or almost significant for 0.5 (SMD = 0.26, p = 0.051), but differences did not reach statistical significance for r =0.2 (SMD = 0.21, p = 0.112).
There was also a strong trend towards significantly increased subtraction task accuracy following 860 mg green oat extract ( p = 0.051: d = 0.48).
For post-eating hunger ratings, marginal significance were observed for stress ( F (10,85) = 3.94, t stress = 1.985; p = 0.051) and condition ( F (10,85) = 3.94 t control = −1.937; p = 0.057).
The mean fullness score for the PGX (granules) meal was also significantly higher at time points 15, 30, 45, and 60 min (5.9, 5.7, 4.9, 4.3 respectively) than for the WD meal (3.5, 2.8, 2.2, 1.4 respectively) (all p < 0.01) and showed a strong trend towards being higher at 90 min ( p = 0.051).
Similarly, within-group changes in the 50-mg group indicated a statistical trend ( p = 0.051) for peak extension power values to change across time.
However, differences between levels were close to being statistically significant ( p = 0.051).
Similarly, higher erythrocyte EPA approached significance ( p = 0.051) with better physical function score.
For leucine AUC, a significant treatment effect was found ( p < 0.001), while the time effect approached significance ( p = 0.051).
LNFP III exhibited a gradual decrease over time in Se+/Le+ and Se−Le+ milk ( p < 0.001), with only marginally significant change observed in Se+/Le− milk ( p = 0.051).
FGF21 showed a trend ( p = 0.051) in overall change in participants following the LCHF diet after decreasing from a median (IQR) of 148.16 (203.49) to 99.4 (92.43) pg/mL at week 4 and increasing again to 167.38 (152.08) pg/mL at week 8, with post-hoc analysis reporting a trend ( p = 0.069) between baseline and week 4, whereas no change was observed in HCLF.
application of vitamin C resulted in a strong trend towards an increase over time from day 1 to day 8 ( p = 0.051; Figure 1 , small insert).
When examining the association with MEDAS-R, the MoCA showed a trend that did not reach statistical significance (β = 0.008; 95% CI [−0.00005 to 0.015]; p = 0.051).
In relation to the nutrient intake, non-fasters had an almost significant increased consumption of calories ( p = 0.051), significantly lower intake of protein ( p = 0.010), higher total sugars ( p = 0.020), higher cholesterol ( p = 0.049), and higher alcohol consumption ( p = 0.009).
The vigorous PA MET was marginally significant: F (1,39) = 4.06 and p = 0.051.
As expected, urinary glucose was higher in individuals with T2D (2.31 ± 6.21 g/L) compared to those with preDM (0.08 ± 0.05 g/L) and NonDM (0.45 ± 1.42 g/L), with a p -value close to significance ( p = 0.051).
Fasting C-peptide levels showed a marginal trend toward higher values on the day of pelemir-enriched bread consumption (median: 2.1 [0.7–7.1] ng/mL vs. 2.0 [0.6–4.1] ng/mL; p = 0.051).
The CFS score remained a significant predictor for mortality (30-day mortality: aOR = 1.359, 95% CI: 1.181–1.564, p < 0.001; 90-day: aOR = 1.326, 95% CI: 1.064–1.440, p < 0.001), with the interaction term between CFS and malnutrition approaching significance for 30-day mortality (aOR = 1.236, 95% CI: 0.999–1.530, p = 0.051).